Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Janngo is an Africa-focused venture capital and start-up studio platform founded by Fatoumata Bâ in 2018. The firm builds, grows, and invests in pan-African digital champions, with a gender-lens strategy that emphasizes women-led or women-benefiting businesses. Its investment focus spans technology and tech-enabled companies addressing access to essential services such as healthcare, education, financial services, logistics, retail, food and agribusiness, mobility, and the creative economy. Janngo is not a biotech or pharmaceutical company; rather, it is an investment and ecosystem-building platform that may back healthcare-related startups among a broader portfolio. The organization operates from Abidjan and Paris and manages Janngo Capital startup funds for seed and early-stage investing across Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Janngo.